Emicizumab in Patients With Acquired Hemophilia A
Emicizumab in Patients With Acquired Hemophilia A
Active, not recruiting · NCT05345197 · Registry updated 2025-11-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Emicizumab in Patients With Acquired Hemophilia A | acquired hemophilia A | Active, not recruiting | Phase 2 | 2025-11-05 | NCT05345197 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Genentech, Inc. | 221 |
| University of Washington | 397 |
16 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Bleeding and Clotting Disorders Institute | Peoria | United States | 3 |
| Emory University | Atlanta | United States | 33 |
| Georgetown University | Washington D.C. | United States | 38 |
| Hemophilia Center of Western Pennsylvania | Pittsburgh | United States | 7 |
| Indiana Hemophilia and Thrombosis Center, Inc. | Indianapolis | United States | 1 |
| Mayo Clinic | Rochester | United States | 664 |
| Penn Blood Disorders Program, Hospital of the University of Pennsylvania | Philadelphia | United States | 1 |
| Tulane University | New Orleans | United States | 1 |
| UCSD Hemophilia and Thrombosis Treatment Center | San Diego | United States | 1 |
| University of North Carolina | Chapel Hill | United States | 38 |
| University of Oklahoma Health Sciences Center | Oklahoma City | United States | 491 |
| University of Vermont Medical Center | Burlington | United States | 157 |
| UVA Comprehensive Cancer Center | Charlottesville | United States | 3 |
| Versiti Inc. | Milwaukee | United States | 1 |
| Washington Center for Bleeding Disorders | Seattle | United States | 5 |
| Washington University | St Louis | United States | 182 |